Development of BCR-ABL1-positive ɤδ T-cell leukemia after treatment for thymoma type B1

Click to increase image sizeClick to decrease image size

Author contributions

TT and KM wrote and edited the manuscript and performed patient care and the literature review; HA performed continuous thymoma therapy and patient care; DI, AK, RT, TT, DM, KN, and MT assisted in providing patient care; NT and KT performed the pathological review and edited the manuscript.

Acknowledgements

We would like to thank all technicians at the Clinical Pathology Department at Kameda Medical Centre and Ms. Tomoe Ando (Department of Clinical Laboratory, Kameda Medical Centre, Chiba, Japan) for their assistance in performing with the FCM analysis. We would also like to thank Dr. Junji Suzumiya (Department of Hematology, KOHKA Public Hospital, Kohka, Japan) and Dr. Kazuo Oshimi (Division of Hematology, Kushiro Rosai Hospital, Kushiro, Japan) for their invaluable advice. We also thank Editage (www.editage.jp) for English language editing. No funding was obtained for this study.

Disclosure statement

The authors report no conflicts of interest.

Patient consent

The patient provided consent for the publication of this case with the removal of all identifying information to remain anonymous and retain her privacy.